Introduction
Limitations
Substance Concentration
The interference listed below have been tested and shown no apparent
influence on results at the normal or higher therapy levels.
5
Other interfering substances in ISO 15197 Annex A are not verified, it may
also affect the test results.
Substance
Acetaminophen
Bilirubin
Creatinine
Gentisic acid
Haemoglobin
Ibuprofen
L-Dopa
Methyl-DOPA
Tolbutamide
Triglycerides
Xylose
EDTA
Substance
Ascorbic acid
Cholesterol
Dopamine
Glutathione
Heparin
Icodextrin
Maltose
Salicylate
Tolazamide
Uric acid
Pralidoxime Iodide
Galactose
Concentration
1.11 mmol/L (20 mg/dL)
2.22 mmol/L (40 mg/dL)
0.56 mmol/L (10 mg/dL)
1.25 mmol/L (22.5 mg/dL)
1111.11 mol/L (20000 mg/dL)
2.78 mmol/L (50 mg/dL)
0.03 mmol/L (0.5 mg/dL)
0.22 mmol/L (4 mg/dL)
5.55 mmol/L (100 mg/dL)
83.33 mmol/L (1500 mg/dL)
2.78 mmol/L (50 mg/dL)
11.11 mmol/L (200 mg/dL)
Concentration
0.17 mmol/L (3 mg/dL)
27.78 mmol/L (500 mg/dL)
1.1 mmol/L (20 mg/dL)
2.17 mmol/L (39 mg/dL)
500 IU/dL
60.8 mmol/L (1094.4 mg/dL)
555.56 mmol/L (10000 mg/dL)
3.33 mmol/L (60 mg/dL)
0.56 mmol/L (10 mg/dL)
1.33 mmol/L (24 mg/dL)
0.83 mmol/L (15 mg/dL)
0.83 mmol/L (15 mg/dL)
